Explore CHRNA2 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels formed by a pentameric arrangement of alpha and beta subunits to create distinct muscle and neuronal receptors. Neuronal receptors are found throughout the peripheral and central nervous system where they are involved in fast synaptic transmission. This gene encodes an alpha subunit that is widely expressed in the brain. The proposed structure for nAChR subunits is a conserved N-terminal extracellular domain followed by three conserved transmembrane domains, a variable cytoplasmic loop, a fourth conserved transmembrane domain, and a short C-terminal extracellular region. Mutations in this gene cause autosomal dominant nocturnal frontal lobe epilepsy type 4. Single nucleotide polymorphisms (SNPs) in this gene have been associated with nicotine dependence. [provided by RefSeq, Nov 2009]
| Target ID |
GM-T55815
|
| Target Name |
CHRNA2
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
1135
|
| Gene ID |
100060380 (Equus caballus), 101092104 (Felis catus), 110902 (Mus musculus), 1135 (Homo sapiens) 170945 (Rattus norvegicus), 486101 (Canis lupus familiaris), 531838 (Bos taurus), 712868 (Macaca mulatta)
|
| Target Alternative Names |
ACHR,Acra-2,Acra2,CHRNA2,Chrna2,Neuronal acetylcholine receptor subunit alpha-2,nica2
|
| Uniprot Accession |
Q91X60,Q15822,P12389
|
| Protein Sub-location |
Transmembrane Protein
|
| Category |
Therapeutics Target
|
| Disease from KEGG |
Neuroactive ligand-receptor interaction
|
| Gene Ensembl |
ENSMUSG00000022041, ENSG00000120903, ENSCAFG00845011451, ENSBTAG00000002252, ENSMMUG00000021514
|
Pre-made viral vector of CHRNA2 cDNA Clones/ORF Plasmid
CHRNA2 siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo1135 | Pre-made Human CHRNA2 siRNA oligo Duplex | 1135 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo170945 | Pre-made Rat Chrna2/ACHR siRNA oligo Duplex | 170945 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo110902 | Pre-made Mouse Chrna2/Acra2/Acra-2 siRNA oligo Duplex | 110902 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo712868 | Pre-made Cynomolgus/Rhesus macaque CHRNA2/nica2 siRNA oligo Duplex | 712868 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101092104 | Pre-made Cat/Feline CHRNA2 siRNA oligo Duplex | 101092104 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo486101 | Pre-made Dog/Canine CHRNA2 siRNA oligo Duplex | 486101 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo531838 | Pre-made Bovines/Cattle CHRNA2 siRNA oligo Duplex | 531838 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100060380 | Pre-made Equine/Horse CHRNA2 siRNA oligo Duplex | 100060380 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
CHRNA2 antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T55815-Ab | Human | Anti-Human CHRNA2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-rg-T55815-Ab | Rat | Anti-Rat CHRNA2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-mg-T55815-Ab | Mouse | Anti-Mouse CHRNA2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T55815-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque CHRNA2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-felg-T55815-Ab | Cat/Feline | Anti-Cat/Feline CHRNA2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cang-T55815-Ab | Dog/Canine | Anti-Dog/Canine CHRNA2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T55815-Ab | Bovines/Cattle | Anti-Bovines/Cattle CHRNA2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-equg-T55815-Ab | Equine/Horse | Anti-Equine/Horse CHRNA2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
CHRNA2 VLP (virus-like particle)/protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T55815-Ag | Human | Human CHRNA2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-rg-T55815-Ag | Rat | Rat CHRNA2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-mg-T55815-Ag | Mouse | Mouse CHRNA2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cynog-T55815-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque CHRNA2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-felg-T55815-Ag | Cat/Feline | Cat/Feline CHRNA2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cang-T55815-Ag | Dog/Canine | Dog/Canine CHRNA2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-bovg-T55815-Ag | Bovines/Cattle | Bovines/Cattle CHRNA2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-equg-T55815-Ag | Equine/Horse | Equine/Horse CHRNA2 VLP (virus-like particle) | HEK293 | Products Developing |